Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Angiotensin Receptor Antagonists"" wg kryterium: Temat


Tytuł:
A Case of Trauma-Related Angioedema of the Airway in a Patient on an Angiotensin Receptor Blocker.
Autorzy:
Allihien SM; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Ibrahim S; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Chaparala S; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Singireddy S; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Kesiena O; Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Feb 28; Vol. 25, pp. e943407. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Angioedema*/chemically induced
Female ; Humans ; Aged, 80 and over ; Telmisartan/adverse effects ; Bradykinin ; Intubation ; Edema
Czasopismo naukowe
Tytuł:
Knowledge, attitudes, and practices regarding antibiotic use and resistance among health science and non-health science university students in Thailand.
Autorzy:
Precha N; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.; Excellent Center for Dengue and Community Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Sukmai S; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Hengbaru M; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Chekoh M; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Laohaprapanon S; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Makkaew P; Department of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.; Excellent Center for Dengue and Community Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Dom NC; Centre of Environmental Health and Safety Studies, Facultyof Health Sciences, Universiti Teknologi MARA (UiTM), Selangor, Malaysia.; Integrated Mosquito Research Group (I-MeRGe), Universiti Teknologi MARA (UiTM), Selangor, Malaysia.; Institute for Biodiversity and Sustainable Development (IBSD), Universiti Teknologi MARA (UiTM), Selangor, Malaysia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 05; Vol. 19 (1), pp. e0296822. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*
Health Knowledge, Attitudes, Practice*
Animals ; Humans ; Cross-Sectional Studies ; Thailand ; Universities ; Angiotensin-Converting Enzyme Inhibitors ; Students ; Anti-Bacterial Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups.
Autorzy:
Lithovius R; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Mutter S; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Parente EB; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Mäkinen VP; Systems Epidemiology, Faculty of Medicine, University of Oulu, Oulu, Finland.; Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland.
Valo E; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Harjutsalo V; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
Groop PH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland. .; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. .; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland. .; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia. .; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki University, Haartmaninkatu 8 [C318b], PO Box 63, 00014, Helsinki, Finland. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 19; Vol. 13 (1), pp. 17893. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Angiotensin Receptor Antagonists*/pharmacology
Diabetes Mellitus, Type 1*/drug therapy
Humans ; Female ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Kidney ; Glomerular Filtration Rate
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Angiotensin Receptor Blockers in Pediatric Patients (Aged 6 to 18) with Hypertension: A Systematic Review.
Autorzy:
Bassiri S
Bakhtiari E
Ghaffarian N
Moazzen N
Ravanshad Y
Azarfar A; Kidney Transplantation Complications Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. .
Pokaż więcej
Źródło:
Iranian journal of kidney diseases [Iran J Kidney Dis] 2023 May; Vol. 17 (3), pp. 117-125.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/adverse effects
Hypertension*/drug therapy
Child ; Humans ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Antihypertensive Agents/adverse effects ; Losartan/adverse effects ; Tetrazoles/adverse effects ; Blood Pressure ; Receptors, Angiotensin/therapeutic use
Czasopismo naukowe
Tytuł:
Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
Autorzy:
Zhang L; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, 411100, China.
Liu Z; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, 411100, China.; Graduate Collaborative Training Base of Xiangtan Central Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Zhu Y; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, 411100, China.; Graduate Collaborative Training Base of Xiangtan Central Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.; Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Wu M; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, 411100, China.; Graduate Collaborative Training Base of Xiangtan Central Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Huang H; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, 411100, China.
Yang W; Medical Department, Xiangtan Central Hospital, Xiangtan, 411100, China.
Peng K; Department of Scientific Research, Xiangtan Central Hospital, Xiangtan, 411100, China. .
Zeng J; Department of Cardiology, Xiangtan Central Hospital, Xiangtan, 411100, China. .; Graduate Collaborative Training Base of Xiangtan Central Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Mar 30; Vol. 19 (1), pp. 163. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
ST Elevation Myocardial Infarction*/surgery
Percutaneous Coronary Intervention*/adverse effects
Humans ; Prognosis ; Patient Discharge ; Retrospective Studies ; Stroke Volume ; Angiotensin Receptor Antagonists ; Aftercare ; Ventricular Function, Left ; Angiotensin-Converting Enzyme Inhibitors ; Natriuretic Peptide, Brain
Czasopismo naukowe
Tytuł:
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.
Autorzy:
Schaefer F; Pediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany. .
Montini G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Department of Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Kang HG; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Walle JV; Department of Pediatric Nephrology, Ghent University Hospital, Erknet Center, C4C, Ghent, Belgium.
Zaritsky J; Department of Nephrology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Schreuder MF; Department of Pediatric Nephrology, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.
Litwin M; Department of Nephrology and Arterial Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
Scalise A; Bayer Hispania, S.L, Sant Joan Despi, Barcelona, Spain.
Scott H; Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
Potts J; Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
Iveli P; Bayer AG, Wuppertal, Germany.
Breitenstein S; Bayer AG, Wuppertal, Germany.
Warady BA; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.; Children's Mercy Kansas City, Kansas City, MO, USA.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 21; Vol. 25 (1), pp. 203. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Diabetic Nephropathies*/drug therapy
Naphthyridines*
Adult ; Humans ; Child ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Proteinuria/drug therapy ; Proteinuria/chemically induced ; Mineralocorticoid Receptor Antagonists/adverse effects
Czasopismo naukowe
Tytuł:
Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
Autorzy:
Schrag A; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Kostev K; University Clinic, Philipps-University, Marburg, Germany.; Epidemiology, IQVIA, Frankfurt, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0299985. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Parkinson Disease*/diagnosis
Parkinson Disease*/drug therapy
Parkinson Disease*/epidemiology
Hypertension*/complications
Hypertension*/drug therapy
Hypertension*/epidemiology
Humans ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/pharmacology ; Case-Control Studies ; Calcium Channel Blockers/therapeutic use ; Primary Health Care ; Angiotensin Receptor Antagonists/therapeutic use
Czasopismo naukowe
Tytuł:
Wounds of Companion Animals as a Habitat of Antibiotic-Resistant Bacteria That Are Potentially Harmful to Humans-Phenotypic, Proteomic and Molecular Detection.
Autorzy:
Lenart-Boroń A; Department of Microbiology and Biomonitoring, Faculty of Agriculture and Economics, University of Agriculture in Kraków, Adam Mickiewicz Ave. 24/28, 30-059 Krakow, Poland.
Stankiewicz K; Department of Microbiology and Biomonitoring, Faculty of Agriculture and Economics, University of Agriculture in Kraków, Adam Mickiewicz Ave. 24/28, 30-059 Krakow, Poland.
Czernecka N; Scientific Circle of Biotechnologists, Faculty of Biotechnology and Horticulture, University of Agriculture in Kraków, 29 Listopada Ave. 54, 31-425 Krakow, Poland.
Ratajewicz A; Scientific Circle of Biotechnologists, Faculty of Biotechnology and Horticulture, University of Agriculture in Kraków, 29 Listopada Ave. 54, 31-425 Krakow, Poland.
Bulanda K; Department of Forest Ecosystems Protection, Faculty of Forestry, University of Agriculture in Kraków, 29 Listopada Ave. 46, 31-425 Kraków, Poland.
Heliasz M; Scientific Circle of Biotechnologists, Faculty of Biotechnology and Horticulture, University of Agriculture in Kraków, 29 Listopada Ave. 54, 31-425 Krakow, Poland.
Sosińska D; Scientific Circle of Biotechnologists, Faculty of Biotechnology and Horticulture, University of Agriculture in Kraków, 29 Listopada Ave. 54, 31-425 Krakow, Poland.
Dworak K; Diagnostyka S.A. Medical Microbiological Laboratory, Na Skarpie 66, 31-913 Krakow, Poland.
Ciesielska D; The University Centre of Veterinary Medicine, Adam Mickiewicz Ave. 24/28, 30-059 Krakow, Poland.
Siemińska I; The University Centre of Veterinary Medicine, Adam Mickiewicz Ave. 24/28, 30-059 Krakow, Poland.
Tischner M; Department of Animal Reproduction, Anatomy and Genomics, Faculty of Animal Science, Adam Mickiewicz Ave. 24/28, 30-059 Krakow, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 08; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Pets*/microbiology
Humans ; Animals ; Escherichia coli ; Tylosin ; Angiotensin Receptor Antagonists ; Proteomics ; Angiotensin-Converting Enzyme Inhibitors ; Bacteria/genetics ; Imipenem ; Ecosystem ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł:
Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium.
Autorzy:
Kourek C; Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece.
Briasoulis A; Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece.
Papamichail A; Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece.
Xanthopoulos A; Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Tsougos E; Department of Cardiology, Hygeia Hospital, 15123 Athens, Greece.
Farmakis D; Attikon University Hospital, Medical School of Athens, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Paraskevaidis I; Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Heart Failure*
Urea/*analogs & derivatives
Humans ; Stroke Volume ; Hydralazine/pharmacology ; Hydralazine/therapeutic use ; Isosorbide Dinitrate/pharmacology ; Isosorbide Dinitrate/therapeutic use ; Angiotensin Receptor Antagonists/pharmacology ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.
Autorzy:
Wang N; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhang C; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/etiology
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin Receptor Antagonists/pharmacology ; Kidney/pathology
Czasopismo naukowe
Tytuł:
Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
Autorzy:
Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, California, USA.
Haslam A; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States.
Prasad V; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7049.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Metformin*/therapeutic use
Humans ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Randomized Controlled Trials as Topic ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Anti-Inflammatory Agents ; Aspirin/therapeutic use ; Antihypertensive Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study.
Autorzy:
Lee DY; Department of Biomedical Informatics, Ajou University School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.
Kim C; Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.
Kim J; Big Data Department, Health Insurance Review and Assessment Service, Wonju, Korea.
Yun J; Big Data Department, Health Insurance Review and Assessment Service, Wonju, Korea.
Lee Y; Big Data Department, Health Insurance Review and Assessment Service, Wonju, Korea.
Chui CSL; School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administration Region, Hong Kong, China.; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administration Region, Hong Kong, China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong Special Administration Region, Hong Kong Science Park, Hong Kong, China.
Son SJ; Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea.
Park RW; Department of Biomedical Informatics, Ajou University School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. .; Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea. .
You SC; Department of Biomedicine Systems Informatics, Yonsei University College of Medicine, Seoul, Korea. .; Institute for Innovation in Digital Healthcare, Yonsei University, 50-1 Yonsei-ro, Seodaemungu, Seoul, 03722, Republic of Korea. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Feb 16; Vol. 24 (1), pp. 128. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Schizophrenia*/complications
Schizophrenia*/drug therapy
Schizophrenia*/chemically induced
Hypertension*/complications
Hypertension*/drug therapy
Hypertension*/diagnosis
Adult ; Humans ; Antihypertensive Agents/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Angiotensin Receptor Antagonists/adverse effects ; Sodium Chloride Symporter Inhibitors/adverse effects ; Cohort Studies
Czasopismo naukowe
Tytuł:
Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage.
Autorzy:
Palffy E; Novartis Ireland Limited, Dublin, Ireland.
Lewis DJ; Patient Safety & Pharmacovigilance, Development, Novartis Pharma GmbH, Wehr, Germany.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, England.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 08; Vol. 19 (2), pp. e0295226. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Aminobutyrates*/therapeutic use
Heart Failure*/drug therapy
Humans ; Valsartan/therapeutic use ; Biphenyl Compounds/therapeutic use ; Drug Utilization ; Drug Combinations ; Tablets/therapeutic use ; Tetrazoles/therapeutic use ; Stroke Volume ; Angiotensin Receptor Antagonists/therapeutic use
Czasopismo naukowe
Tytuł:
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy.
Autorzy:
Chiang CH; Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Chang YC; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
Wang SS; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
Chen YJ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
See XY; Department of Medicine, Unity Hospital, Rochester Regional Health, Rochester, New York, USA.
Peng CY; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
Hsia YP; Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Chiang CH; Department of Medical Education, Kuang Tien General Hospital, Taichung, Taiwan.; London School of Hygiene & Tropical Medicine, London, UK.
Chiang CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of General Division, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Peng CM; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9583-9588. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers*/pharmacology
Angiotensin II Type 1 Receptor Blockers*/therapeutic use
Angiotensin Receptor Antagonists*/therapeutic use
Humans ; PPAR gamma/metabolism ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Immunotherapy
Czasopismo naukowe
Tytuł:
Adaptation and initial validation of the Arabic version of the Word Memory Test (WMT ARB ).
Autorzy:
Bajjaleh C; Department of Psychology, the Academic College of Tel Aviv-Yaffo, Tel Aviv-Yaffo, Israel.
Braw YC; Department of Psychology, Ariel University, Ariel, Israel.
Elkana O; Department of Psychology, the Academic College of Tel Aviv-Yaffo, Tel Aviv-Yaffo, Israel.
Pokaż więcej
Źródło:
Applied neuropsychology. Adult [Appl Neuropsychol Adult] 2023 Mar-Apr; Vol. 30 (2), pp. 204-213. Date of Electronic Publication: 2021 May 27.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Angiotensin Receptor Antagonists*
Memory Disorders*/diagnosis
Adult ; Humans ; Angiotensin-Converting Enzyme Inhibitors ; Malingering/diagnosis ; Neuropsychological Tests ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation.
Autorzy:
Dong Y; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Zhai Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Wang J; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Xia Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Xia Z; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Zhu B; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Dong Q; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Li Q; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China.
Li J; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1 of Minde Road, Nanchang, 330006, China. juxiang__.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 23; Vol. 13 (1), pp. 3140. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/prevention & control
Neprilysin*/antagonists & inhibitors
Humans ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/therapeutic use ; Receptors, Angiotensin ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study.
Autorzy:
Nguyen NTH; School of Health Care Administration, College of Management, Taipei Medical University, Taipei 11031, Taiwan.; Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue 491-20, Vietnam.
Nguyen PA; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei 106339, Taiwan.; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.
Huang CW; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.
Wang CH; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Biomedical Informatics & Data Science (BIDS) Section, School of Medicine, Johns Hopkins University, 2024 E Monument St, Suite 1-200, Baltimore, MD 21205, USA.
Lin MC; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235041, Taiwan.; Taipei Neuroscience Institute, Taipei Medical University, Taipei 11031, Taiwan.
Hsu MH; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei 106339, Taiwan.; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei 11031, Taiwan.
Bao HB; Health Personnel Training Institute, University of Medicine and Pharmacy, Hue University, Hue 491-20, Vietnam.; Internal Medicine Department, University of Medicine and Pharmacy, Hue University, Hue 491-20, Vietnam.
Chien SC; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.
Yang HC; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.; International Center for Health Information Technology (ICHIT), College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 106339, Taiwan.; Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei 116079, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 14; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin Receptor Antagonists*/therapeutic use
Angiotensin-Converting Enzyme Inhibitors*/therapeutic use
Endometrial Neoplasms*/epidemiology
Hypertension*/drug therapy
Ovarian Neoplasms*/epidemiology
Renin-Angiotensin System*/drug effects
Female ; Humans ; Case-Control Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy.
Autorzy:
Iwane S; Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, 577-8502, Japan.; Department of Pharmacy, Kansai Medical University Hospital, Hirakata, 573-1191, Japan.
Nemoto W; Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, 981-8558, Japan.
Miyamoto T; Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, 577-8502, Japan.; School of Pharmacy, Hyogo Medical University, Kobe, 650-8530, Japan.
Hayashi T; Department of Pharmacy, Kindai University Nara Hospital, Ikoma, 630-0293, Japan.
Tanaka M; Department of Pharmacy, Kansai Medical University Hospital, Hirakata, 573-1191, Japan.
Uchitani K; Department of Pharmacy, Kansai Medical University Hospital, Hirakata, 573-1191, Japan.
Muranaka T; Department of Pharmacy, Kansai Medical University Hospital, Hirakata, 573-1191, Japan.
Fujitani M; Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, 594-0076, Japan.
Koizumi Y; Department of Pharmacy, Seichokai Fuchu Hospital, Izumi, 594-0076, Japan.
Hirata A; Department of Pharmacy, Kindai University Nara Hospital, Ikoma, 630-0293, Japan.
Tsubota M; Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, 577-8502, Japan.
Sekiguchi F; Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, 577-8502, Japan.
Tan-No K; Division of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, 981-8558, Japan.
Kawabata A; Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University, Higashi-Osaka, 577-8502, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 10; Vol. 14 (1), pp. 1039. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Neuropathies*/drug therapy
Diabetic Neuropathies*/prevention & control
Animals ; Mice ; Humans ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin Receptor Antagonists/therapeutic use ; Antihypertensive Agents ; Retrospective Studies ; Antiviral Agents
Czasopismo naukowe
Tytuł:
Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk.
Autorzy:
Wongcharoen W; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd., Sriphoom, Muang Chiang Mai, 50200, Thailand.
Osataphan N; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd., Sriphoom, Muang Chiang Mai, 50200, Thailand.
Gunaparn S; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd., Sriphoom, Muang Chiang Mai, 50200, Thailand.
Srimahachota S; Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Porapakkham P; Central Chest Institute of Thailand, Nonthaburi, Thailand.
Dutsadeevettakul S; Department of Medicine, Golden Jubilee Medical Center, Mahidol University, Nakhon Pathom, Thailand.
Phrommintikul A; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd., Sriphoom, Muang Chiang Mai, 50200, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 27; Vol. 13 (1), pp. 23066. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Cardiovascular Diseases*
Heart Failure*
Humans ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Antihypertensive Agents/pharmacology ; Longitudinal Studies ; Prospective Studies ; Renin-Angiotensin System ; Risk Factors
Czasopismo naukowe
Tytuł:
Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension.
Autorzy:
Zhang Z; Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Wu S; Department of Military Health Statistics, Naval Medical University, Shanghai, 200433, China.
Wang Z; Department of Information Management, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, 200434, China.
Wang Y; Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Chen H; Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Wu C; Department of Military Health Statistics, Naval Medical University, Shanghai, 200433, China. .
Xiong L; Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Dec 18; Vol. 23 (1), pp. 882. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/complications
Hypertension*/drug therapy
Hypertension*/complications
Respiratory Insufficiency*/complications
Aged ; Humans ; Angiotensin Receptor Antagonists/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Retrospective Studies ; China/epidemiology ; Patient Acuity
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies